Form 4: Chemours Executive Boosts Stake with Over $190,000 in Common Stock Purchases
Insider Transaction Report
Damian Gumpel, President of Titanium Technologies at The Chemours Company, acquired 21,222 shares of common stock across two transactions in early June 2025, increasing his total beneficial ownership to 131,701 shares.
Summary
- Damian Gumpel, President of Titanium Technologies at The Chemours Company (CC), reported two separate purchases of the company's common stock.
- On June 2, 2025, Mr. Gumpel acquired 13,400 shares of common stock at a price of $9.22 per share, totaling $123,548.
- On June 3, 2025, an additional 7,822 shares were purchased at $9.9499 per share, amounting to approximately $77,808.
- Following these transactions, Mr. Gumpel's total beneficial ownership in The Chemours Company increased to 131,701 shares.
- The reported beneficial ownership includes both directly owned shares and restricted stock units.
Sentiment
Score: 8
Explanation: The sentiment is highly positive due to substantial insider buying by a key executive, which typically signals strong confidence in the company's valuation and future performance.
Positives
- The acquisition of 21,222 shares by a key executive, Damian Gumpel, signals strong insider confidence in the company's future performance and valuation.
- Insider buying can often be interpreted by the market as a positive indicator, suggesting that management believes the stock is undervalued or expects positive developments.
Future Outlook
NA
Industry Context
This Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends. However, insider buying can be a signal of management's perception of the company's position within its industry.
Stakeholder Impact
- Shareholders may view these insider purchases as a positive sign, potentially increasing investor confidence and demand for the stock.
- Employees might perceive this as a sign of stability and positive outlook from leadership.
Key Dates
| Date | Description |
|---|---|
| 06/02/2025 | Date of transaction for the acquisition of 13,400 shares of Common Stock. |
| 06/03/2025 | Date of transaction for the acquisition of 7,822 shares of Common Stock. |
| 06/04/2025 | Date the Form 4 filing was signed. |
Recommendation
buyKeywords
Chemours, CC, insider trading, stock purchase, Form 4, beneficial ownership, Damian Gumpel, Titanium Technologies, executive stock acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.